Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our goal is to prospect the relationships between Bisphenol A (BPA) exposure (measured as its free and conjugated forms in blood and urine) and embryo implantation rate (measured as the ratio between the number of gestational sacs and the number of transferred embryos) after assisted reproductive technology. In order to reduce the confusion factors, the population study is limited to young women (aged 28 to 34), with regular menstrual cycles and without any medical event that could affect the implantation process

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

At High-risk for Pre-eclampsia After Assisted Reproductive Technology

NCT05746793

Pre-Eclampsia

RECRUITING

Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome

NCT06918236

Fetal Growth Restriction (FGR) Preeclampsia Stillbirth +3 more

RECRUITING

Could Bisphenol-A Have a Role in the Etiology of Neural Tube Defects

NCT05454085

Neural Tube Defects Bisphenol-A

COMPLETED NA

Impact of UFPs and MNPs on Fetal Health

NCT07238608

Pregnant Women

RECRUITING

Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.

NCT02174328

Pre-Eclampsia

TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Among the various suspected adverse effects of BPA on human health, studies on the possible effects of BPA on reproduction are limited. Animal and in vitro studies indicate that BPA exposure can lead to disrupted oocyte maturation, E2 suppression and early pregnancy loss caused by chromosomal abnormalities. In the woman, studies about the consequences of BPA exposure on reproduction is a very difficult task since gametogenesis in the woman spreads over decades, from the intra-uterine life where meiosis is initiated to the end of the reproductive period at menopause. Recently, a decreased survival of human foetal oocytes cultured in vitro in the presence of BPA has been shown suggesting that in vivo exposure in foetal life could affect the ovarian reserve. Furthermore, a negative association between urinary BPA level and serum peak E2, oocyte yield and blastocyst formation has been suggested on a limited population of women performing ART. These results suggest that, in adulthood, both quantity and quality of human oocytes could be affected by BPA exposures. The study aims to respond to these questions by evaluating the relationships between BPA exposition levels and embryo implantation rates (as a marker of oocyte quality) and anti-Mullerian hormon (AMH) levels (as a marker of ovarian reserve) in large population of young adult women performing ART. BPA exposure will be assessed at two times in both blood and urine: 1°) before the ovarian stimulation at the time of ovarian reserve tests and 2°) at the end of the ovarian stimulation the day of the ovarian puncture for IVF.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Reproductive Problem Male Reproductive Problems

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

couples

couples attending an IVF or intra cytoplasmic sperm injection (ICSI) attempt have hormonal and blood analysis

Group Type EXPERIMENTAL

hormonal and blood analysis

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hormonal and blood analysis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Couples attending an IVF or ICSI attempt whose woman is aged 28 ans to 34 at inclusion time
* Regular menstrual cycles (between 27 and 33 days)
* 1st or 2nd IVF or ICSI attempt with an embryo transfer at D2 or D3

Exclusion Criteria

* couple already included in the study
* ovarian surgery history
* uterine (malformation, diethylstilbestrol (DES) syndrome, adenomyosis…) or systemic pathology that can affect implantation (thrombophilia, antiphospholipids syndrome…)
* chemotherapy history for the woman
* any endocrinopathy (except dysthyroid) in the woman
* any pelvic surgery for the woman in the 3 months preceding inclusion
* endometriosis
* ICSI with testicular sperm
* Positive viral load for HIV, hepatitis C virus or hepatitis B virus (HCV or HBV) during the year preceding inclusion in one or both members of the couple

Minimum Eligible Age

28 Years

Maximum Eligible Age

34 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No